PD 21 - Tackling Unmet Medical Needs of Vulnerable and Neglected Populations

Despite much progress, poverty related infectious diseases (PRDs) are still responsible for a huge burden in Africa. As well as their impact on individuals, these diseases – in particular, tuberculosis, HIV/AIDS and malaria – and the neglected and emerging diseases, impose a high economic burden on countries, acting as a drag on national development. Achieving most if not all Sustainable Development Goals (SDGs) will depend on effective control of infectious diseases through enhanced detection, treatment, prevention and tracking of infection. The development of fast, reliable, user-friendly and cost-effective medical technologies is needed to streamline diagnostic processes in resource-limited settings, to support preventive measures as well as reducing unnecessary referrals and ensuring early initiation of treatment when needed.

To optimally contribute to clinical decision-making and working practices in existing healthcare systems, it is important to evaluate the effectiveness of promising new generations of medical technologies in real life situations. Moreover, antimicrobial resistance (AMR) is already having a major impact in developing countries especially in Africa, compromising the use of multiple antibiotics against target pathogens, as well as antimalarial, antiviral and antifungal therapeutics. Key to reducing the threat of AMR is the development of better diagnostic and prognostic tools, ideally for use at point-of-care.

This session will discuss general strategies and provide practical examples of the clinical development of novel medical technologies for PRDs through partnerships and strategic alliances.